Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR

被引:80
作者
Zirnstein, G
Helsel, L
Li, Y
Swaminathan, B
Besser, J
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, US PHS, US Dept HHS, Atlanta, GA 30333 USA
[2] Minnesota Dept Hlth, Minneapolis, MN USA
关键词
Campylobacter coli; ciprofloxacin resistance; mismatch polymerase chain reaction; gyrA mutation;
D O I
10.1016/S0378-1097(00)00306-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Increasing numbers of fluoroquinolone-resistant Campylobacter ter coli isolates received at the Minnesota State Public Health Laboratory and at the Centers for Disease Control and Prevention have been a cause for concern. The gyrA quinolone resistance-determining regions of several fluoroquinolone-resistant isolates were sequenced to examine the mechanism of resistance. Ciprofloxacin-resistant C. coli isolates examined by DNA sequencing had a Thr-86 to Ile (ACT --> ATT) gyrA mutation, leading to resistance to fluoroquinolone antibiotics. A mismatch amplification mutation assay polymerase chain reaction protocol was developed to detect this gyrA mutation. (C) 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 28 条
[1]  
ABRAMOWITZ M, 1998, MED LETT HDB ANTIMIC, P43
[2]   DEVELOPMENT OF RESISTANCE TO QUINOLONES IN 5 PATIENTS WITH CAMPYLOBACTERIOSIS TREATED WITH NORFLOXACIN OR CIPROFLOXACIN [J].
ADLERMOSCA, H ;
LUTHYHOTTENSTEIN, J ;
LUCCHINI, GM ;
BURNENS, A ;
ALTWEGG, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (11) :953-956
[3]  
Cha R S, 1992, PCR Methods Appl, V2, P14
[4]  
Charvalos E, 1996, J CLIN LAB ANAL, V10, P129, DOI 10.1002/(SICI)1098-2825(1996)10:3<129::AID-JCLA3>3.0.CO
[5]  
2-6
[6]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
[7]   Ciprofloxacin resistant Campylobacter spp in humans: An epidemiological and laboratory study [J].
Gaunt, PN ;
Piddock, LJV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) :747-757
[8]  
GILBERT DN, 1999, SANDFORD GUIDE ANTIM, P12
[9]   Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant [J].
Gonzalez, I ;
Grant, KA ;
Richardson, PT ;
Park, SF ;
Collins, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) :759-763
[10]   NOVEL QUINOLONE RESISTANCE MUTATIONS OF THE ESCHERICHIA-COLI DNA GYRASE A-PROTEIN - ENZYMATIC ANALYSIS OF THE MUTANT PROTEINS [J].
HALLETT, P ;
MAXWELL, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :335-340